-
公开(公告)号:US20240360434A1
公开(公告)日:2024-10-31
申请号:US18533836
申请日:2023-12-08
申请人: QIAGEN GmbH
发明人: Kalle GÜNTHER , Ralf WYRICH , Uwe OELMÜLLER
IPC分类号: C12N15/10 , C12Q1/6806
CPC分类号: C12N15/1003 , C12Q1/6806
摘要: The present invention pertains to a method for isolation and purification of nucleic acids from a stabilized sample or portion or fraction thereof, wherein the sample stabilization involved the use of at least one formaldehyde releaser and wherein the isolation of the nucleic acids from the stabilized sample or portion or fraction thereof involves the use of at least one cationic detergent during lysis.
-
公开(公告)号:US12123870B2
公开(公告)日:2024-10-22
申请号:US17018199
申请日:2020-09-11
申请人: QIAGEN GmbH
IPC分类号: B01L3/00 , C12Q1/68 , G01N33/543
CPC分类号: G01N33/54366 , B01L3/5027 , C12Q1/68 , B01L2200/0605 , B01L2200/0684 , B01L2200/16 , B01L2300/0816 , B01L2300/0864 , B01L2300/087 , B01L2300/0883 , B01L2400/0457 , B01L2400/0487
摘要: A fluidic testing system and method for use are presented. The fluidic testing system includes a microfluidic channel, a first chamber and second chamber. The microfluidic channel has only one port for the introduction and/or extraction of fluid through the microfluidic channel. The first chamber is disposed at a terminal end of the microfluidic channel. The second chamber is coupled to the fluidic channel and is aligned such that each opening to the second chamber is configured to be aligned substantially parallel to a gravity vector during operation.
-
公开(公告)号:US20240287574A1
公开(公告)日:2024-08-29
申请号:US18376137
申请日:2023-10-03
申请人: QIAGEN GmbH
IPC分类号: C12Q1/68 , C12N15/10 , C12Q1/6806
CPC分类号: C12Q1/68 , C12N15/1003 , C12Q1/6806
摘要: The present invention provides methods, compositions and devices for stabilizing the extracellular nucleic acid population in a cell-containing biological sample using an apoptosis inhibitor, preferably a caspase inhibitor, a hypertonic agent and/or a compound according to formula 1 as defined in the claims.
-
公开(公告)号:US20240287498A1
公开(公告)日:2024-08-29
申请号:US18570344
申请日:2022-06-15
申请人: QIAGEN GmbH
发明人: Martin SCHLUMPBERGER
IPC分类号: C12N15/10
CPC分类号: C12N15/1013
摘要: The present invention provides methods and kits for isolating cell-free, non-vesicular miRNAs from a biological sample, such as serum and plasma, by using an acidic binding buffer comprising a buffering agent to promote binding of non-vesicular miRNAs to a solid phase comprising anion exchange groups. Furthermore, binding of non-vesicular miRNAs to the solid phase may be improved due to the presence of a crowding agent and by increasing the surface charge density of the solid phase.
-
公开(公告)号:US20240084363A1
公开(公告)日:2024-03-14
申请号:US18482273
申请日:2023-10-06
申请人: QIAGEN GmbH
IPC分类号: C12Q1/6827 , C12Q1/6806 , C12Q1/6851 , C12Q1/686 , C12Q1/6876 , C12Q1/6879
CPC分类号: C12Q1/6827 , C12Q1/6806 , C12Q1/6851 , C12Q1/686 , C12Q1/6876 , C12Q1/6879 , C12Q2525/151 , C12Q2600/16 , C12Q2600/166
摘要: Oligonucleotide primers and probes for quantifying and/or detecting human male DNA in a forensic sample. The oligonucleotides are useful for amplifying a multicopy locus within the human Y-chromosome (MCL-Y) that shares at least 80% sequence identity to a sequence according to SEQ ID NO. 3 over a stretch of at least 60 base pairs. The oligonucleotides hybridize under stringent conditions to a nucleic acid having at least one sequence selected from the group consisting of SEQ ID NO. 3 to SEQ ID NO. 11 and/or SEQ ID NO. 17 to SEQ ID NO. 25. Kits including the oligonucleotide primers, probes and/or primer pairs and reagents for performing an amplification reaction on DNA recovered from a forensic sample are also disclosed.
-
公开(公告)号:US20230028205A1
公开(公告)日:2023-01-26
申请号:US17785478
申请日:2020-12-16
申请人: QIAGEN GmbH
IPC分类号: C12N15/10
摘要: A method is provided for enriching extracellular DNA from a biological sample comprising extracellular DNA and extracellular vesicles, wherein the method comprises: (a) preparing a binding mixture comprising—the biological sample, —a solid phase comprising anion exchange groups, —an acidic binding buffer comprising a buffering agent, and binding extracellular DNA to the solid phase comprising anion exchange groups; (b) separating the solid phase with the bound extracellular DNA from the remaining binding mixture, wherein the remaining binding mixture comprises extracellular vesicles. The method may furthermore comprise processing the remaining binding mixture to enrich one or more biological targets of interest therefrom, wherein processing may comprise (c) enriching as biological targets extracellular vesicles and/or extracellular RNA from the remaining binding mixture.
-
公开(公告)号:US20220340954A1
公开(公告)日:2022-10-27
申请号:US17620615
申请日:2020-06-26
申请人: QIAGEN GmbH
发明人: Lothar BREITKOPF , Jasper STROEDER
IPC分类号: C12Q1/6806 , C12N15/10
摘要: The present invention provides a poly(alkylene oxide) polymer based size selective nucleic acid enrichment method for enriching target nucleic acid molecules from a nucleic acid containing sample which comprises target nucleic acid molecules and non-target nucleic acid molecules, wherein the target nucleic acid molecules are longer than the non-target nucleic acid molecules, the method comprising (a) preparing a binding mixture comprising—the nucleic acid containing sample, —a poly(alkylene oxide) polymer and—a salt and binding nucleic acid molecules to a solid phase which comprises a functional group, preferably carboxylated magnetic particles, wherein the bound nucleic acid molecules comprise target nucleic acid molecules; (b) preferably separating the solid phase with the bound nucleic acid molecules from the remaining sample; (c) contacting the solid phase with the bound nucleic acid molecules at least once with a reagent composition comprising a poly(alkylene oxide) polymer and a salt to selectively elute non-target nucleic acid molecules, wherein the concentration (w/v) of the poly(alkylene oxide) polymer in the reagent composition of step (c) is lower than the concentration (w/v) of the poly(alkylene oxide) polymer in the binding mixture of step (a); (d) optionally washing the bound target nucleic acid molecules; and (e) eluting the bound target nucleic acid molecules from the solid phase. Said method allows the size selective purification of target DNA molecules and is particularly suitable for sequencing applications. It is more time- and cost efficient than prior art methods and provides excellent purification results. Moreover, further methods and kits are provided.
-
公开(公告)号:USD961430S1
公开(公告)日:2022-08-23
申请号:US29729584
申请日:2020-03-27
-
公开(公告)号:US20220204968A1
公开(公告)日:2022-06-30
申请号:US17695270
申请日:2022-03-15
申请人: QIAGEN GmbH
发明人: Roland Fabis , Anke Homann , Thorsten Voss , Thomas Hanselle
摘要: The present invention relates to a lysis, binding and/or wash reagent for isolating and/or purifying nucleic acids and a method for isolating and/or purifying nucleic acids.
-
公开(公告)号:US20210254032A1
公开(公告)日:2021-08-19
申请号:US17181787
申请日:2021-02-22
申请人: QIAGEN GMBH
发明人: Ralf Peist , Frank Narz , Nicole Grasse , Anne Schieren , Thea Rutjes
IPC分类号: C12N9/12
摘要: The present invention relates to a family B polymerase enzyme comprising the following mutations, a mutation in the motif A region, wherein a threonine is the second amino acid of the motif A region, wherein the motif A region is homologous to amino acids 408 to 410 in 9° N, a mutation leading to a reduction or elimination of the 3′-5′ exonuclease activity if present in said family B polymerase, wherein said polymerase additionally comprises one or both of the following mutations in the motif A region, L408Y or L408F and/or P410S or P410G. It may be used in DNA sequencing and may be present in a kit.
-
-
-
-
-
-
-
-
-